
Alerts, recalls and safety information
This safety information is provided by the Medicines and Healthcare products Regulatory Agency (MHRA), the UK regulator for medicines and medical devices. These alerts may cover medicines, vaccines or medical devices, and can include new safety warnings, prescribing advice, product recalls or field safety notices. They are issued to protect patients and to help healthcare professionals provide safe, effective care.
Patient.info republishes these updates so that both professionals and the public can access the latest official safety communications in one place.
/og.png)
NGPod pH testing device: quarantine and dispose of all devices (DSI/2026/009)
by Medicines and Healthcare products Regulatory Agency (MHRA)

Field Safety Notices: 17 to 21 August 2026
by Medicines and Healthcare products Regulatory Agency (MHRA)
A%2F37/og.png)
Class 2 Medicines Recall: Zentiva Pharma UK Limited, Fingolimod Zentiva 0.5 mg Capsules, EL(26)A/37
by Medicines and Healthcare products Regulatory Agency (MHRA)
%3A%20Do%20not%20use%20in%20infants%2C%20including%20for%20the%20treatment%20of%20colic%2C%20gas-related%20discomfort%20or%20constipation%20(DSI%2F2026%2F008)/og.png)
All rectal catheters (gas and colic relievers): Do not use in infants, including for the treatment of colic, gas-related discomfort or constipation (DSI/2026/008)
by Medicines and Healthcare products Regulatory Agency (MHRA)
MHRA Safety Roundup: August 2026Summary of the latest safety advice for medicines and medical device users Read the full update from MHRA About MHRA alerts and recalls The Medicines and Healthcare products Regulatory Agency (MHRA) is the UK’s regulator...
By Medicines and Healthcare products Regulatory Agency (MHRA)
NGPod pH testing device: quarantine and dispose of all devices (DSI/2026/009)The NGPod handheld device and NGPod sensor, used to test pH to aid the placement of nasogastric tubes, is being withdrawn from the UK market. The manufacturer has ceased trading in the UK. Users should quarantine all rem...
By Medicines and Healthcare products Regulatory Agency (MHRA)
Field Safety Notices: 17 to 21 August 2026List of Field Safety Notices from 17 to 21 August 2026. Read the full update from MHRA About MHRA alerts and recalls The Medicines and Healthcare products Regulatory Agency (MHRA) is the UK’s regulator for medicines, vac...
By Medicines and Healthcare products Regulatory Agency (MHRA)
Class 2 Medicines Recall: Zentiva Pharma UK Limited, Fingolimod Zentiva 0.5 mg Capsules, EL(26)A/37Zentiva UK Pharma Limited are recalling one batch of Fingolimod Zentiva 0.5 mg Capsules (BN 4L01372H) as a precautionary measure due to a potential risk of contamination with metal particles. Read the full update from MH...
By Medicines and Healthcare products Regulatory Agency (MHRA)
All rectal catheters (gas and colic relievers): Do not use in infants, including for the treatment of colic, gas-related discomfort or constipation (DSI/2026/008)Do not use rectal catheters in infants, including for colic, gas-related discomfort or constipation. Stop using these products immediately and dispose of any unused devices. Read the full update from MHRA About MHRA aler...
By Medicines and Healthcare products Regulatory Agency (MHRA)
Field Safety Notices: 10 to 14 August 2026List of Field Safety Notices from 10 to 14 August 2026. Read the full update from MHRA About MHRA alerts and recalls The Medicines and Healthcare products Regulatory Agency (MHRA) is the UK’s regulator for medicines, vac...
By Medicines and Healthcare products Regulatory Agency (MHRA)
National Patient Safety Alert: ResMed Astral 100 and 150 Ventilators: Potential for Patient Harm due to Unexpected Interruption of Ventilation Therapy (NatPSA/2026/004/MHRA)ResMed has issued a Field Safety Notice regarding Astral 100 and 150 ventilators and associated Printed Circuit Board Assembly spare parts manufactured prior to October 2024. A fault in the device can cause unexpected in...
By Medicines and Healthcare products Regulatory Agency (MHRA)
Field Safety Notices: 3 to 7 August 2026List of Field Safety Notices from 3 to 7 August 2026. Read the full update from MHRA About MHRA alerts and recalls The Medicines and Healthcare products Regulatory Agency (MHRA) is the UK’s regulator for medicines, vacci...
By Medicines and Healthcare products Regulatory Agency (MHRA)
Devices supplied without valid UKCA/CE conformity markings or certification: remove from use and place in quarantine (DSI/2026/007)The MHRA has become aware of a number of medical devices being supplied on the UK market that do not comply with the requirements of the UK Medical Device Regulations 2002 (UK MDR 2002) or with the EU Medical Devices Reg...
By Medicines and Healthcare products Regulatory Agency (MHRA)
Belzer UW® Cold Storage Solution and Belzer MPS® (UW Machine Perfusion Solution): manufactured by Carnamedica (UKRP: Bridge to Life): Updated advice on the contamination of fluid DSI/2026/006 (update to DSI/2023/005)The MHRA is providing an update on defects previously identified with Belzer solutions for the preservation of donated organs. This DSI replaces advice in DSI/2023/005. Read the full update from MHRA About MHRA alerts an...
By Medicines and Healthcare products Regulatory Agency (MHRA)
Field Safety Notices: 27 to 31 July 2026List of Field Safety Notices from 27 to 31 July 2026 Read the full update from MHRA About MHRA alerts and recalls The Medicines and Healthcare products Regulatory Agency (MHRA) is the UK’s regulator for medicines, vaccin...
By Medicines and Healthcare products Regulatory Agency (MHRA)
Dräger Atlan Anaesthesia workstations: risk of ventilator failure (DSI/2026/005)In April 2026, Dräger issued a follow-up Field Safety Notice expanding the number of Atlan Anaesthesia workstation devices affected by a manufacturing defect that may result in mechanical ventilation failure. Read the fu...
By Medicines and Healthcare products Regulatory Agency (MHRA)
MHRA Safety Roundup: July 2026Summary of the latest safety advice for medicines and medical device users Read the full update from MHRA About MHRA alerts and recalls The Medicines and Healthcare products Regulatory Agency (MHRA) is the UK’s regulator...
By Medicines and Healthcare products Regulatory Agency (MHRA)
Field Safety Notices: 20 to 24 July 2026List of Field Safety Notices from 20 to 24 July 2026. Read the full update from MHRA About MHRA alerts and recalls The Medicines and Healthcare products Regulatory Agency (MHRA) is the UK’s regulator for medicines, vacci...
By Medicines and Healthcare products Regulatory Agency (MHRA)
Class 4 Medicines Defect Notification: Neuraxpharm UK Ltd, Tuzulby prolonged-release chewable tablets, EL(26)A/36Neuraxpharm UK Ltd has informed the MHRA of missing safety information in the Patient Information Leaflet (PIL) and Summary of Product Characteristics (SmPC) for certain batches of Tuzulby prolonged release 20mg, 30mg an...
By Medicines and Healthcare products Regulatory Agency (MHRA)
Domperidone: new contraindication in patients with phaeochromocytoma due to the risk of severe hypertensionThe product information has been updated for all domperidone products, to include a contraindication for patients with confirmed or suspected phaeochromocytoma (a rare tumour of the adrenal gland), due to the risk of epi...
By Medicines and Healthcare products Regulatory Agency (MHRA)
Field Safety Notices: 13 to 17 July 2026List of Field Safety Notices from 13 to 17 July 2026. Read the full update from MHRA About MHRA alerts and recalls The Medicines and Healthcare products Regulatory Agency (MHRA) is the UK’s regulator for medicines, vacci...
By Medicines and Healthcare products Regulatory Agency (MHRA)
Class 4 Medicines Defect Notification: Macarthys Laboratories Ltd T/A Martindale Pharma, Xaggitin XL Prolonged-release Tablets, EL(26)A/35Macarthys Laboratories Ltd T/A Martindale Pharma has notified the MHRA of a manufacturing issue impacting several batches of Xaggitin XL Prolonged-release Tablets, due to the occurrence of incorrect tablet counts in the...
By Medicines and Healthcare products Regulatory Agency (MHRA)
Botulinum toxin type A products: updated warnings regarding risk of iatrogenic botulismCases of iatrogenic botulism have been reported following the therapeutic or cosmetic use of botulinum toxin containing products where the toxin’s effect extends beyond the area of treatment. Patients should seek immedia...
By Medicines and Healthcare products Regulatory Agency (MHRA)
Field Safety Notices: 6 to 10 July 2026List of Field Safety Notices from 6 to 10 July 2026. Read the full update from MHRA About MHRA alerts and recalls The Medicines and Healthcare products Regulatory Agency (MHRA) is the UK’s regulator for medicines, vaccin...
By Medicines and Healthcare products Regulatory Agency (MHRA)